Prot #CNTO1959PSO3011: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Ped

Project: Research project

Project Details

StatusActive
Effective start/end date4/19/19 → 11/7/25

Funding

  • Janssen Research & Development, LLC (Prot #CNTO1959PSO3011)